These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Therapeutic effectiveness of the transdermal system with nitroglycerin in comparison with nifedipine]. Wester HA; Mouselimis N Z Kardiol; 1984 Aug; 73(8):510-4. PubMed ID: 6437092 [TBL] [Abstract][Full Text] [Related]
28. Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study. Colombo G; Favini G; Aglieri S; Pollavini G; de Vita C Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):211-4. PubMed ID: 3922903 [TBL] [Abstract][Full Text] [Related]
29. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment. Chu LC; Gale RM; Schmitt LG; Shaw JE Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484 [TBL] [Abstract][Full Text] [Related]
30. [An analysis of the concentration-effect relation of glyceryl trinitrate in patients with stenocardia of effort after its single use in prolonged-release drug forms]. Blagodatskikh SV; Piotrovskiĭ VK; Metelitsa VI; Martsevich SIu; Riabokon' OS Farmakol Toksikol; 1989; 52(5):77-81. PubMed ID: 2513227 [TBL] [Abstract][Full Text] [Related]
31. Comparative pharmacokinetics and bioavailability of nitroglycerin and its metabolites from Transderm-Nitro, Nitrodisc, and Nitro-Dur II systems using a stable-isotope technique. Sun JX; Piraino AJ; Morgan JM; Joshi JC; Cipriano A; Chan K; Redalieu E J Clin Pharmacol; 1995 Apr; 35(4):390-7. PubMed ID: 7650229 [TBL] [Abstract][Full Text] [Related]
33. [Pharmacodynamic equivalence and clinical trial of a new fluorocarbon-free glycerol trinitrate pump spray with low ethanol content in comparison to a fluorocarbon-containing reference spray and a fluorocarbon-free pump spray with high ethanol content]. Erb K; de Mey C; Zimmermann T; Mutschler H; Roll S; Belz GG Arzneimittelforschung; 1994 Apr; 44(4):478-82. PubMed ID: 8011000 [TBL] [Abstract][Full Text] [Related]
34. Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature. Barkve TF; Langseth-Manrique K; Bredesen JE; Gjesdal K Am Heart J; 1986 Sep; 112(3):537-41. PubMed ID: 3092610 [TBL] [Abstract][Full Text] [Related]
35. Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isosorbide dinitrate. Kelly EA; Ahmed RM; Horowitz JD Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):269-72. PubMed ID: 15810990 [TBL] [Abstract][Full Text] [Related]
36. The effect of hydralazine on the development of tolerance to continuous nitroglycerin. Parker JD; Parker AB; Farrell B; Parker JO J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301 [TBL] [Abstract][Full Text] [Related]
37. Topical nitroglycerin versus lateral internal sphincterotomy for chronic anal fissure: prospective, randomized trial. Mishra R; Thomas S; Maan MS; Hadke NS ANZ J Surg; 2005 Dec; 75(12):1032-5. PubMed ID: 16398803 [TBL] [Abstract][Full Text] [Related]
38. Endothelin ETA receptor antagonist did not affect development of tolerance to glyceryl trinitrate in rat. Rai A; Bhalla S; Gulati A J Pharm Pharmacol; 2004 Feb; 56(2):271-5. PubMed ID: 15005887 [TBL] [Abstract][Full Text] [Related]
39. Determination of glyceryl trinitrate and its two main metabolites in human plasma using a new sensitive gas chromatography method. Ghandforoush-Sattari M; Zakeri-Milani P; Mashayekhi S; Valizadeh H Arzneimittelforschung; 2011; 61(3):141-7. PubMed ID: 21528637 [TBL] [Abstract][Full Text] [Related]
40. A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open, randomized, cross-over trial. Facchinetti F; Sgarbi L; Piccinini F; Volpe A Gynecol Endocrinol; 2002 Feb; 16(1):39-43. PubMed ID: 11915580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]